Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
332.4 329 313.7 306.4 326.2 Last
7130545 5113990 5728607 5424430 4901433 Volume
-4.76% -1.02% -4.65% -2.33% +6.46% Change
Financials ( DKK)
Sales 2016 116 547 M
EBIT 2016 50 630 M
Net income 2016 39 300 M
Finance 2016 11 563 M
Yield 2016 2,26%
Sales 2017 125 158 M
EBIT 2017 54 757 M
Net income 2017 43 285 M
Finance 2017 14 865 M
Yield 2017 2,52%
P/E ratio 2016 21,05
P/E ratio 2017 18,78
EV / Sales 2016 5,67x
EV / Sales 2017 5,26x
Capitalization 672 808 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas... 
Sector
Pharmaceuticals
Calendar
03/01Presentation
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
02/10 NOVO NORDISK A/S : Bestyrelsesmedlemmers, koncerndirektørers og nærtstående pers..
02/10 NOVO NORDISK A/S : files annual report with the SEC
02/10 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/10 NOVO NORDISK A/S : Bestyrelsesmedlemmers, koncerndirektørers og nærtstående pers..
02/10DJSanofi's Diabetes Approach Stumbles
02/09DJSanofi Is Forced to End Latest Diabetes Effort
02/08 NOVO NORDISK A/S : Going Integrated for the 12th Time: Novo Nordisk Publishes 20..
02/08 NOVO NORDISK A/S : aktietilbagekøbsprogram
More news
Sector news : Pharmaceuticals - NEC
02:28a HIKMA PHARMACEUTICALS : *hsbc cuts hikma pharmaceuticals price target to 2525 pe..
01:33a GLAXOSMITHKLINE : *ubs raises glaxosmithkline price target to 1420 pence - 'neut..
01:16a NOVARTIS : Sandoz advances its biosimilars program with EMA acceptance of regula..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/06 NOVO NORDISK : Don't Get Scared By Foolish Investor Sentiment
02/05 Novo Nordisk Takes NASH Treatment Another Step Forward
02/03 Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings C..
02/03 Novo Nordisk reports Q4 and FY15 results
02/03 Novo Nordisk reports Q4 results


Comments 
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions